Top
Events

Théa news

Find out all the latest news on Théa

 To consolidate its presence on the front of research and innovation, Théa participates in all national and international congresses and meetings dedicated to ophthalmology and opted to partner many subspecialty meetings.

Congresses, conferences, product launches, scientific innovation, innovation, new offices, Théa is always on the move.

 

 

Record participation for 6th TROPHY
Event

STARS : identifier la DMLA chez les patients à risque

220 young ophthalmologists from more than 21 countries submitted clinical cases in answer to the topic of the sixth edition of the TROPHY contest – ‘novel management of  ocular surface diseases’...Read More

 

 

more

Welcome, Théa Pamex Ireland!
Théa worldwide

STARS : identifier la DMLA chez les patients à risque

After Mexico in 2014, Morocco and Russia in 2015, Ukraine, Dubai and Saudi Arabia in 2016, it is now Ireland’s turn to welcome a new subsidiary of Théa Laboratories...Read More

 

more

Thea supports Ophthalmologists at recent Birmingham meeting
Education

STARS : identifier la DMLA chez les patients à risque

Thea UK were delighted to support the Thea Birmingham Corneal Meeting recently...Read More

more

DRY LAB workshops for young ophthalmologists
Education

STARS : identifier la DMLA chez les patients à risque

During 2 vital national conferences; Théa France organised its first DRY LAB workshops dedicated to young ophthalmologists...Read More

more

Laboratoires Théa partner of ESCRS Winter 2018
Education

STARS : identifier la DMLA chez les patients à risque

Laboratoires THEA participated in the 22nd European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meeting, which took place in Belgrade, Serbia, from 9 to 11 February 2018, a great opportunity to meet Eastern Europe's ophthalmologists...Read more

more

Théa welcomes 400 ophthalmologists at JRO
Education

STARS : identifier la DMLA chez les patients à risque

For the seventh consecutive year, Théa organised a France/Maghreb meeting with Dr Lazreg & Dr Santiago on the theme of surgical retina. 400 ophthalmologists participated in this event at the 18th Ophthalmological Reflections Days in Paris...Read more

more

Partnership
Théa is entering the retina field by virtue of an agreement concluded with ELSALYS BIOTECH

STARS : identifier la DMLA chez les patients à risque

The THEA laboratories are expanding their portfolio to include the retina owing to a licence option on an antibody in the treatment of humid AMD, and other retina vascular pathologies: ELB011...Read more
more

Event
An unprecedented meeting!

STARS : identifier la DMLA chez les patients à risque

On Thursday, 25 January 2018, Jean-Frédéric CHIBRET met with Mr Emmanuel MACRON, President of the French Republic...Read More
more

Education
THEA at the ESCRS 2017partner through activities during ESCRS

STARS : identifier la DMLA chez les patients à risque

THEA provides surgeons with innovative products as well as YOs with DRY LAB sessions to develop surgical skills.
New ways to prevent ocular dryness and simplified management of cataract patient thanks to intracameral injection have been raised during educational symposia....Read more
more

Event
Frank G. Holz receives the Paul Chibret medal

STARS : identifier la DMLA chez les patients à risque

Prof. Dr. Med. Frank G. Holz was awarded the Paul Chibret medal at the DOG 2017 Congress in Berlin....Read More
more

Innovation by Théa
Trehalose and Thealoz® Duo in the spotlight of the TFOS DEWS II

STARS : identifier la DMLA chez les patients à risque

For the first time, the TFOS has officially acknowledged trehalose as an effective ingredient in association with hyaluronic acid for the treatment of dry eye syndrome. Thealoz® Duo (Théalose® in France), medical device developed by Théa, has a unique mode of action associating both sodium hyaluronate (hyaluronic acid) for its lubricant properties and trehalose for its bioprotectant properties...Read more
more

Event
TROPHY competition 5th edition

STARS : identifier la DMLA chez les patients à risque

116 young ophthalmologists from over 21 countries submitted a clinical case in response to the subject chosen for the TROPHY 5th edition: “The non-surgical treatment of corneal diseases”...Read More

more

Industry
Production practically doubled!

STARS : identifier la DMLA chez les patients à risque

The Fareva group, and more specifically its subsidiary Excelvision, has opened a new single-dose sterile production unit with Théa Laboratories. This new building will be capable of manufaturing 800 million preservative-free single doses per year, as opposed to the 500 million produced today....Read More

more

Théa Worldwide
Launching Théa Pharmaceuticals in the Middle East

STARS : identifier la DMLA chez les patients à risque

Following Mexico in 2014, Morocco and Russia in 2015 and Ukraine in 2016, it is now Dubai’s turn to witness the opening of a new subsidiary of Théa Laboratories...Read More

more

Event
3rd Eye Nutrition Meeting

STARS : identifier la DMLA chez les patients à risque

90 ophthalmologists from 14 different countries attended a Théa event on the latest developments in eye health, including the benefits of nutrition, predominantly vitamin D...Read more

more

Education to surgery by Théa
THEA supports YOs to develop surgical skills

STARS : identifier la DMLA chez les patients à risque

THEA organised and sponsored the 1st international dry lab session during the SOE Congress in Barcelona (June 2017) in partnership with the YO-SOE Board. As education is part of Thea’s ethos we are advancing into providing Surgical Skills Training for Young Ophthalmic surgeons using the latest innovative apparatus and simulation eyes. ...Read more
more

AMD
STARS: 13 risks factors to identify patients at risk of AMD

STARS: 13 risks factors to identify patients at risk of AMDA new simple and fast questionnaire has been developed by Laboratoires Théa in order to assess early AMD risk... Read more

more

Ophthalmic surgical world
How to generate fast dilation?

Thanks to many years of experience and intense research, Théa has found a new way to generate faster and stable dilation. Taking the opportunity of the ESCRS international congress, Théa shared this innovation with several thousand ophthalmologists coming from all over Europe... Read more

more

A new book on how to manage chronic corneal ulcers.
« Chronic Corneal Ulcers »

« Chronic Corneal Ulcers » European ophthalmological professors have joined together in order to present an all-encompassing book on the complicated topic of Chronic Corneal Ulcers. This book is aimed at ophthalmologists in order to improve cornea care... Read more

more

History
« Les Chibret, une saga auvergnate (1875-2015) »

Book "Les Chibret, une saga auvergnate (1875-2015)"Written by Lorraine Kaltenbach under the direction of Henri Chibret, this saga relates the history of the Chibret’s family since the French revolution up until today; but above all the close relationship that family members have always maintained with ophthalmological workers... Read more

more

Fifteen years of innovation
15th anniversary of Théa PHARMA, Switzerland

 

Team Thea PHARMA SWITZERLANDFounded in 2001, Théa PHARMA Switzerland began their journey with only 2 products. Today their range of both innovative and well-known products covers almost every ophthalmological therapeutic class... Read more

more

Education
Théa, partner of the Young Ophthalmologists

The second edition of the European Meeting of Young Ophthalmologists took place in June in Oviedo, Spain. Laboratoires Théa, represented by Jean-Frédéric Chibret, the President of the company, was the main partner and sponsor of the event... Read more

more

Innovation by Théa
A new era in mydriasis


Théa is very keen on innovating in all therapeutic areas in ophthalmology, including cataract surgery.  

To develop its new product indicated in the mydriasis (pupil dilation) for patients undergoing cataract surgery, Théa set up clinical studies to demonstrate the efficacy and the safety of the product... Read more

 

more

Théa worldwide
Official opening of the Théa office in Ukraine

After Mexico in 2014, Morocco and Russie in 2015, it is now in Ukraine that Théa has opened their latest new representative office. The Ambassador of France in Ukraine, Isabelle Dumont, Prof. Vitovska, the Head of Ukrainian ophthalmologists and Jean-Frédéric Chibret, President of Théa, were present for this event... Read more

more

Théa worldwide
15th anniversary of Théa Pharma Belgium

The Théa story in Belgium started in 2000 when Théa accepted the challenge to break new ground in preservative-free eye care in Benelux.
... Read more

more

Careers
Developing international mobility

Supporting the integration and mobility of employees across the Group is Théa’s aspiration to ensure the career development of each individual...Read more

more

Preservative free
A new brochure on 25 years of Preservative-free eye drops

Preservative-free is in the DNA of Laboratoires Théa and is part of its history. Increase the awareness of the ophthalmologists to the importance of Preservative-free eye drops remains a priority with one goal: 0% Preservatives...Read more

more

Glaucoma treatment
a new association of anti-glaucoma active ingredients in a preservative-free bottle


Innovation in the area of preservative-free eye drops is one of the most important interests of Théa’s research and development.

Théa Pharma Germany presented the new Théa preservative-free association of two anti-glaucoma active ingredients at the DOG congress in Düsseldorf in March 2016. This product is distributed in a multidose bottle using EasyGrip® technology.

.. Read more

 

more